Sarah Sung, MD is an assistant professor in the department of neurology at the University of Oklahoma Health Sciences Center. She specializes in the treatment of Brain Tumors and is a member of the Comprehensive Brain Tumor Program.
Her research interests include treatment of glioblastoma and other primary central nervous system tumors, such as low-grade or anaplastic astrocytoma, low-grade or anaplastic oligodendroglioma, ependymoma, and meningioma
She is a member of the American Academy of Neurology and the Society for Neuro Oncology.
She attended medical school at the OU College of Medicine. She completed her residency at Rush University Medical Center in Chicago and then completed a fellowship in neuro-oncology at UCLA in California. She is board certified in neurology and neuro-oncology.
Fellowship: University of California, Los Angeles; Los Angeles, CA
Residency: Rush University Medical Center, Chicago, IL
Medical School: OU College of Medicine, Oklahoma City, OK
Treatment of glioblastoma and other primary central nervous system tumors, such as low-grade or anaplastic astrocytoma, low-grade or anaplastic oligodendroglioma, ependymoma, and meningioma.
American Academy of Neurology
Society for Neuro-Oncology